ABSTRACT. Thirteen biochemical parameters and five enzymatic activities were determined on sera of 63 normal human fetuses sampled by direct puncture under ultrasound guidance, between the 20th and the 26th wk of gestation, and on their mothers. They were referred to us for various prenatal diagnoses but were well and confirmed healthy at birth. Some parameters were found to be very similar in both groups, mainly creatinine, calcium, creatine kinase, aspartate aminotransferase, and y-glutamyl transferase. Some values were significantly higher in the fetuses, such as total bilirubin, direct bilirubin, phosphorus, lactic dehydrogenase and alkaline phosphatase activities, and afetoprotein. Urea, uric acid, glucose, triglycerides, cholesterol, total protein, and albumin levels were found to be lower in fetuses. These data indicate a slower metabolism in fetuses compared to their mothers, a lower level of energy requirement, and a relative liver immaturity. These normal values of fetal biochemistry will improve our knowledge of physiology and help to determine the specific values of a test in fetal pathology. (Pediatr Res 21: 579-583, 1987)
blood can now be easily obtained by sampling via the umbilical cord, using a needle guided by ultrasound (6, 7) , allowing the prenatal diagnoses of various diseases (8-1 1) . Regarding congenital toxoplasmosis (lo), most of the fetuses (96%) were found to be well, and gave us the opportunity to obtain normal values in hematology (l2), coagulation (l3), for free amino acid (l4), and in endocrinology ( 15, 16) during the 2nd trimester of pregnancy. For this study, we retrospectively selected sera from 63 fetuses sampled between the 20th and the 26th wk of gestation, born healthy at term to establish normal fetal biochemical values. Twelve biochemical parameters: total protein, albumin, urea, total bilirubin, direct bilirubin, cholesterol, triglycerides, glucose, creatinine, uric acid, total calcium, phosphorus, and five enzymatic activities: alkaline phosphatase, aspartate aminotransferase, creatine kinase, lactic dehydrogenase and r glutamyl transferase were determined automatically, and a-fetoprotein was measured by an immunoassay (ELISA). We also measured maternal blood concentration on the day of the fetal sampling to determine a possible relationship between mothers and their fetuses. The results obtained provide useful normal values, which are a prerequisite for prenatal diagnoses of congenital biochemical disorders, for a better approach to normal and abnormal behavior, and possibly in the future for fetal monitoring.
MATERIALS AND METHODS
Patients. Sixty-three pure blood samples were selected retrospectively from fetuses that had undergone blood sampling for prenatal diagnosis of congenital toxoplasmosis between the 20th and the 26th wk of gestation, detected to be well in utero, and confirmed healthy at birth. The mothers had a venipuncture on the day of fetal sampling.
Sampling procedure. Fetal blood was obtained by direct puncture of the umbilical vein near the cord insertion on the placenta as previously described (6, 7) . For this study, 2 ml were obtained and divided into three aliquots: one anticoagulated with EDTA to control purity, one anticoagulated with fluorure oxalate to determine glucose level, and another without additive. Histograms of white and red blood cells provided by a Coulter S plus I1 were automatically recorded and compared with those for maternal blood samples. The Kleihauer Betke staining procedure and isoelectric focusing of hemoglobin were camed out to detect maternal blood contamination. Pure fetal blood was obtained in all cases, without dilution by amniotic fluid or contamination by maternal blood. Blood samples were left 2 h at room temperature for clotting, then the sera (as plasma) were separated by centrifugation and frozen at -80" C until the time of assays.
Biochemical measurements. A multipurpose chemistry analyser, Coulter dacos (discrete analyzer with continuous optical scanning) was used to determine 12 blood substrate concentrations and five enzymatic activities with dart reagents (Coulter Electronics Inc, Hialeah, FL). The required specimen volume ranges between 2 and 20 p1 for each test, so only 150 p1 were required for those 17 determinations.
The principles and procedures of these biochemical analyses have been previously described in detail, and are summarized below. Albumin was determined by a modification of the method of Doumas (bromocresol green) (1 7), the instantaneous initial absorbance at 630 nm was obtained as suggested by Webster (18) . Urea nitrogen was determined by a modification of the method of Marsh et al. (19) (urease). The method used to determine total bilirubin and direct bilirubin was a modification of the Walters and Gerarde (20) method (diazoreaction with 580 FORESTIE sulfanilic acid). The kinetic formation of the diazo dye is different depending on which of the following three derivatives is involved (monoglucuronide, diglucuronide, or unconjugated bilirubin). Bilirubin diglucuronides and a part of the monoglucuronides give the direct reaction. Total bilirubin includes the three bilirubin derivatives. In the presence of cholesterol oxidase and oxygen, the cholesterol is oxidized to cholesten-3-one and hydrogen peroxide. Hydrogen peroxide with a peroxidase, couples a 4-aminoantipyrine and phenol in a quinonimine with an absorbtion at 500 nm. Triglycerides were determined by a modification of the method of Bucolo and David (21) (triglycerol lipase, glycerol kinase). Uric acid was determined by a modification of the method of Fossati et al. (22) (uricase). To determine glycemia, we used a modified hexokinase/glucose-6-phosphate dehydrogenase procedure, which is a national glucose reference method (23). Total protein was measured by a Gornall method, where the color reaction is the basis for biuret test (24) . The method used for creatinine is a modification of the kinetic Jaffe method (25) . Calcium was determined by a modification of the method of Connerty and Briggs (26) (0-cresolphthalein complexone). Phosphorus was determined by a modification of the method of Daly and Ertingshausen (27) (phosphomolybdate coloration). The method used to determine alkaline phosphatase activity was optimized from Bowers and McComb (28) system (p-nitrophenylphosphate). Aspartate aminotransferase activity was determined by a modification of the method optimized by Bergmeyer et al. (29) . Creatine kinase activity was measured according to the method of Rosalki (30) . The reagent includes AMP and diadenosine pentaphosphate to suppress adenylate kinase activity (3 1). Lactate dehydrogenase activity was determined by a modification of the method of Wacker et al. (32) . Gamma-glutamyl transpeptidase activity was determined by a modification of Szasz's method (33) . Reagents were prepared as directed by the manufacturers. Dart calibrators (Coulter Electronics) and internal quality control were used. Alpha-fetoprotein is determined through an immunoassay (ELISA) (TANDEM AFP Biotrol).
Statistical studies. For the 17 biochemical parameters studied on 63 pairs of maternal-fetal blood, reference values were established with means, SD, and confidence limits related to mean. Histograms were constructed. The distribution curve was found to be non-Gaussian. In order to establish the biochemical profile of fetuses, results between 2.5 and 97.5 percentiles were taken into account. rs were computed from the two series of data (collected in fetuses and in pregnant women) in order to shed light on the differences or similarities between these measures. The decision making procedure used in testing the significance of a measure was determined by computing the test (34) .
RESULTS
The results obtained for 63 normal human fetuses and their mothers (means + SD) between the 20th and 26th wk of gestation are given in Table 1 for sera substrate concentrations and in Table 2 for sera enzymatic activities.
The concentrations of two substrates studied are not significantly different in either group: creatinine [64 2 pmol/liter Total serum fetal protein represents half that of maternal serum concentration. Fetal albumin is also lower, as are glucose 2.8 + Figure 1 . Except for triglycerides, the levels of which progressively decreased during the 6 wk studied, and for a-fetoprotein, no correlations were observed between gestational age and blood concentrations for the other biochemical parameters or enzymatic activities. Triglycerides values are proportional to gestational age with the following formula: y = FETAL BIOCHEMISTRY 
DISCUSSION
Normal values of biochemical parameters are clearly established for neonates as well as for premature infants (I). Past studies on the biochemical constituents of fetal blood were taken from fetuses which had been aborted and were therefore restricted to a few selective parameters (2-4). More recently, Moniz et al. (5) reported normal reference ranges for biochemical substances relating to renal, hepatic and bone functions, in fetal blood obtained by fetoscopy in the second trimester of pregnancy, and in maternal plasma (5) . In the present study, the normal values of 13 blood substrate concentrations and five enzymatic activities were determined in samples obtained by direct puncture under ultrasound guidance from normal human fetuses between the 20th and 26th wk of gestation. Compared with earlier studies on term neonates, the main differences concern the levels of albumin and total protein which are lower during early fetal life. The amount of a-fetoprotein progressively decreases from the 18th to 30th wk of gestation ranging from 1344 f 353 to 512 f 195 pglml. These data correlate well with the previously reported decrease of a-fetoprotein in amniotic fluid during this period (19) . In the present study the data ranged from 9.1 + 2.1 pg/ml at the 18th wk to 1.36 + 0.56 pg/ml at the 30th wk. This supports the hypothesis of the decreased synthesis of a-fetoprotein during gestation (36) . In maternal sera we observed a decrease of a-fetoprotein levels. If we take into consideration the albuminla-fetoprotein ratio during the gestational period studied, there is a significant decrease which could be connected with fetal liver maturity. Some recent studies suggest that a-fetoprotein could bind bilirubin as does albumin (37) . That relationship between albumin and a-fetoprotein needs to be investigated more deeply in order to assess fetal development and maturity (38) as well as the measurement of growth-promoting activity (16) . Comparing these figures with those registered for adults, we found the same discrepancy for albumin and total protein, due to the fact that at birth, the levels are the same as in the adult. The very low fetal plasma protein concentration bears out the hypothesis that the placenta is sparingly permeable to vroteins.
Fetal glucose values are half that in the adult, but in good correlation with the maternal level (rs = 0.63 1). Fetal triglycerides are also lower and progressively decrease with a minimum level at birth (39, 40) . As for albumin and total amino acid levels (14) , the decrease of glucose and triglycerides levels in fetuses will involve a reduction of energy supply.
As with other structural substrates, fetal cholesterol was found to be very low (one-fifth of the maternal level). This could reflect a fast utilization in lipid building and a very high lipid turnover during fetal life. Another hypothesis concerns the liver immaturity of fetuses at this stage of development which is demonstrated by the measurement of low activities of coagulation factors synthesized by the liver (1 3).
Total serum calcium concentration was found at the same level in fetuses and mothers, despite low protein and high phosphorus concentrations in the fetuses. There was no correlation between the maternal and fetal calcium, total protein, and phosphorus concentrations. These results are in good correlation with Thalme's (3) reports on aborted products, and we can hypothesize that even if total calcium concentrations are the same in mothers and fetuses, there are some differences in repartition between free and protein-bound calcium. Citrate concentration and the calcium-binding capacity of proteins in fetuses (3, 4) cannot explain the absence of correlation between calcium and FORESTIE :R ET AL.
total protein in fetuses. So with the same fetal calcium concentration, if fetal total protein is less than half of maternal total protein concentration, the fetal ionized calcium concentration must be higher than in mothers, as is the case with the serum phosphorus concentration. Calcium phosphates are poorly dissociated at neutral pH and it seems that placenta is less permeable to undissociated calcium phosphate than to calcium and phosphate ions. Radde et al. (41) prove the existence of a fetomaternal gradient for ionized calcium where placenta plays an active role. This specialized transport has been suggested to be facilitated by the placental calcium pump (42) . There is also an active transfer of phosphorus. Calcium and phosphorus metabolism and transplacental movements concur in obtaining high levels of calcium and phosphorus ions in fetal sera. This, associated with high fetal alkaline phosphatase activities (which is probably of bone origin) (5), could reflect a specific aspect of bone building.
Fetal creatinine level is not different from the level registered in mothers. In contrast the level of urea (the most diffusible molecule) is lower in fetuses. This contradicts animal studies which reported that fetal plasma urea concentrations were higher than maternal values; and there was a constant fetal-maternal gradient across the placenta, over a wide range of urea concentration (43) . Two mechanisms can explain the low level of urea in fetal sera: a poor reabsorption of water by the convoluted tubules of the kidney which increases the clearance of urea in fetuses and a liver immaturity that involves a decrease of amino acid metabolism with a lower generation of urea. In fact the convoluted tubules of the kidney seem to be functional because ions were correctly reabsorbed, therefore the low levels of fetal uremia must be related to a poor production of urea. In addition, amino acid level is lower in fetuses than in adults (14) . Uric acid, as a reflection of cellular replacement, is also lower in fetuses. The study of uric acid precursors in fetuses may tell us if this low level is related to a decreased production or to an increase in the metabolism and elimination.
The total amount of bilirubin is significantly higher and does not differ from that observed at birth (I). As suggested by Moniz et al. (5) , the causes of hyperbilirubinaemia must be considered.
First, the fetal erythrocytes have a shortened life span of about 70 days (44) , and second, the conjugating ability of the liver is still immature. Because of the relatively high level of direct bilirubin, it is necessary to investigate bilirubin mono-and diconjugates. Indeed the presence of bilirubin conjugates in fetal blood could reflect an immaturity of internal liver bile ducts, which could be explored through a study of biliary acids. This observation is usually typical of a retentional syndrome of the bile ducts. However, this goes against the observation that 20% of neonates are born with a failure of glucuronidation. As a matter of fact the fetal liver would only metabolize a minimal part of the bilirubin, with a lack of elimination most of it is eliminated by maternal liver metabolism. The observation of five pregnancies with severe rhesus isoimmunization, which gave us the opportunity to manage fetal blood transfusion in utero, has allowed the study of fetal bilirubin elimination. We never observed any increase of fetal bilirubin, due to the fact that bilirubin is eliminated by the maternal liver.
rs were calculated from the data from 63 fetuses and their related mothers in order to point out a possible correlation between maternal and fetal levels of biochemical substrates and enzymes. For urea, creatinine, glucose, and uric acid, the rs values are higher than 0.6. These data indicate that there is a correlation between maternal and fetal concentrations. From a clinical point of view the measurements of those fetal parameters are not relevant for diagnostic use in utero. For example, an increase of fetal creatinine does not reflect renal insufficiency. In fact we handled a case of severe hydronephritis without alteration of fetal creatinine levels. Spearman coeficient were found to be less than 0.2 for cholesterol, triglycerides, total protein, creatine kinase, lactic dehydrogenase, aspartate aminotransferase, and alkaline phosphatase suggesting that a specific value of those parameters is a real reflection of fetal status. The data provided by these statistical analyses and our reference values greatly contributed to two types of diagnosis. First, after demonstrating that cholesterol in a fetus of 24 wk was one-fifth that of its mother and that there is no correlation between maternal and fetal levels, we have been able to perform the first prenatal diagnosis of hypercholesterolemia in an affected homozygous fetus. The level found was 14.04 mmol/liter (543 mg/dl), contrasting with our usual values 1.5 + 0.05 mmol/liter (58 + 2 mg/ dl). These data were confirmed by the absence of binding of low density lipoprotein receptor activity on fibroblasts (Goldstein JL, Brown MS, unpublished data) and were confirmed on the aborted fetus (1 1). Second, in cases of congenital toxoplasmosis, we usually observed an increase of y-glutamyl transferase and lactic dehydrogenase. Gamma-glutamyl transferase in 163 normal fetuses at risk of toxoplasmosis was 30 & 10 and 180 + 80 IU/liter in affected fetuses (10) . Lactic dehydrogenase was, resvectivelv. 279 + 50 and 480 & 110 IUIliter. The increase of rd~tam~itransferase and lactic dehydrogenase might suggest liver damage. In future these measurements will be helpful as early nonspecific diagnostic markers.
In conclusion, the study reported normal ranges of biochemical parameters in pure fetal blood from healthy fetuses. They have been obtained by the use of a new technique for fetal blood sampling in utero. This knowledge has become indispensable for prenatal diagnoses of biochemical disorders and for further examination of affected fetuses. The correlation observed between the different biochemical levels either in cord sera or in maternal sera or between both pave the way for future studies concerning fetal metabolism. Other reference ranges of biochemical indices need to be established, thus widening the scope for the prenatal diagnosis of other conditions.
